Regulation 15 Exempt activitiesI1

Northern Ireland Not yet in force

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

reg. 15(1) reg. 15 becomes reg. 15(1) by Genetically Modified Organisms 2019 reg. 3(5)(a)
reg. 15(1)(aa) inserted by Genetically Modified Organisms 2019 reg. 3(5)(b)
reg. 15(1)(b) substituted for reg. 15(1)(b)(c) by Genetically Modified Organisms 2019 reg. 3(5)(c)
reg. 15(1)(e) substituted by Genetically Modified Organisms 2019 reg. 3(5)(d)
reg. 15(1)(g) omitted by Genetically Modified Organisms 2019 reg. 3(5)(e)
reg. 15(2) inserted by Genetically Modified Organisms 2019 reg. 3(5)(f)
reg. 15(a) words inserted by Genetically Modified Organisms (Deliberate Release) 2005 reg. 2(3)(a)
reg. 15 coming into force by Genetically Modified Organisms (Deliberate Release) 2003 reg. 1
reg. 15(f) substituted by Genetically Modified Organisms (Deliberate Release) 2005 reg. 2(3)(b)
reg. 15(g) inserted by Genetically Modified Organisms (Deliberate Release) 2005 reg. 2(3)(c)
reg. 15(e) substituted by Pesticides, Genetically Modified Organisms and Fertilisers 2018 reg. 5(3)(a)
reg. 15(f) words substituted by Pesticides, Genetically Modified Organisms and Fertilisers 2018 reg. 5(3)(b)

The cases and circumstances prescribed for the purposes of Article 5(7) and Article 8(7) of the Order in which persons are exempt from the requirements of Article 5(1)(a) of the Order (to carry out a risk assessment) and of Article 8(1)(a) of the Order (to obtain consent), insofar as they relate to marketing genetically modified organisms, are all cases and circumstances in which –

(a)

an approved product is marketed for a use for which it has approval;

(b)

genetically modified micro-organisms are made available for activities regulated under the Contained Use Directive;

(c)

genetically modified organisms other than micro-organisms falling within paragraph (b) are made available to be used exclusively for activities where appropriate stringent containment measures based on the same principles of containment as laid down in the Contained Use Directive are used to limit their contact with and to provide a high level of safety for the general population and the environment;

(d)

genetically modified organisms are made available to be used exclusively for deliberate releases complying with the requirements laid down in Part II;

(e)

a genetically modified organism authorised under Council Regulation (EEC) No. 2309/93^f1, as amended by Commission Regulation EC No 649/98^f2, is marketed; or

(f)

a novel food or novel food ingredient within the scope of Regulation EC No. 258/97 of the European Parliament and of the Council^f3 is marketed.

Regulation 15 Exempt activitiesI1

Annotations

Commencement

Footnotes